Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RWJ-333369 as adjunctive therapy in partial onset seizures
2006-003839-68Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing RWJ-333369 adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoints: Change in partial onset seizure frequency and Percent reduction in seizure frequency. Started Sep 2006; status: completed.
02
Drugs
carisbamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2006-003839-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003839-68.